Dopaminergic, Functional, Structural, and Cognitive Disturbances in First-episode Schizophrenia

NCT00206960 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

56

Enrollment

OTHER

Sponsor class

Conditions

Schizophrenia

Interventions

DRUG: zuclopenthixol
DRUG: risperidone

Sponsor

Birte Glenthoj

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]